dockets: FDA-2019-E-3017
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | title | docket_type | last_modified | object_id | rin | dkabstract | category | subtype | keywords | program | short_title | effective_date | organization | attrs_raw | attr_source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-E-3017 | FDA | Patent Term Extension Application for EMGALITY (galcanezumab-gnlm), Patent No. 9,505,838 | Nonrulemaking | 2025-01-22T16:01:43Z | 0b00006483d396b0 | list_pull |
Links from other tables
- 6 rows from docket_id in documents